Wuhan Keqian Biology Co.,Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 686.52 million compared to CNY 775.73 million a year ago. Revenue was CNY 686.52 million compared to CNY 775.73 million a year ago.

Net income was CNY 283.43 million compared to CNY 385.91 million a year ago. Basic earnings per share from continuing operations was CNY 0.61 compared to CNY 0.83 a year ago. Diluted earnings per share from continuing operations was CNY 0.61 compared to CNY 0.83 a year ago.